DNA / metal organic framework composite nano-enzyme as well as preparation method and application thereof

Through the combination of DNA/metal organic skeleton composite nanoenzyme and hydrogel microneedle, the sampling time-consuming and invasive problems of traditional uric acid detection are solved, and the rapid, safe and accurate uric acid detection is achieved, reducing costs and infection risks. A simple and intuitive uric acid monitoring method is provided.

CN118930883AActive Publication Date: 2024-11-12SHENYANG PHARMA UNIV

Patent Information

Application Number
CN202411031813.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-30
Publication Date
2024-11-12
Estimated Expiration
2044-07-30

AI Technical Summary

Technical Problem

Traditional uric acid detection methods are time-consuming to sample, require complex equipment, cause invasive pain and infection risks to patients, and the natural enzyme costs are high and unstable, making it difficult to achieve rapid, safe and accurate detection.

Method used

The skin interstitial fluid was extracted by DNA/metal organic skeleton composite nanoenzyme combined with hydrogel microneedle, and the uric acid content was detected by the complex nanoenzyme colorimetric method. The metal organic framework modified by metal oxide and heme/G four-strand DNA was extracted. Incubate the preparation of complex nanoenzymes, which have peroxidase activity, catalyze the color changes of the substrate to achieve uric acid detection.

Benefits of technology

It realizes the rapid, safe, painless, minimally invasive and accurate uric acid detection, reduces the detection cost and infection risk, and provides a simple and intuitive uric acid monitoring method.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004970118560000011
    Figure HDA0004970118560000011
  • Figure HDA0004970118560000012
    Figure HDA0004970118560000012
  • Figure HDA0004970118560000013
    Figure HDA0004970118560000013
Patent Text Reader

Abstract

The invention relates to DNA / metal organic framework composite nano-enzyme as well as a preparation method and application thereof, and relates to the technical field of microneedles. The invention relates to a preparation method of DNA (deoxyribonucleic acid) / metal organic framework composite nano-enzyme. The composite nano-enzyme is obtained by jointly incubating a metal oxide modified metal organic framework and heme / G quadruplex DNA. The invention further provides a microneedle detection system based on the composite nano-enzyme. The detection system comprises the composite nano-enzyme and a hydrogel microneedle used for extracting skin interstitial fluid. According to the method, human skin interstitial fluid is extracted through a hydrogel microneedle patch, and the biomarker uric acid in the interstitial fluid is detected by means of a composite nano-enzyme colorimetric method. Compared with a method for detecting uric acid through blood, the method for detecting uric acid is minimally invasive, painless, simple, rapid, visual and accurate.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a DNA / metal organic skeleton composite nanozyme and a preparation method and application thereof, and relates to the technical field of microneedles. Background Art

[0002] Increased uric acid levels in the body are a potential risk factor for chronic kidney disease, gout, cardiovascular disease, and diabetes. Monitoring uric acid in human blood is essential to prevent the occurrence of related diseases. Traditional uric acid testing is done through blood testing, which is not only time-consuming to sample, but also requires the use of complex laboratory equipment for analysis. It also causes patients to feel mental distress, invasive physical pain and trauma, and because the skin barrier is broken, it increases the possibility of infection in patients. The hydrogel microneedle penetrates the stratum corneum of the skin to reach the epidermis and dermis to extract the skin interstitial fluid. Through the detection of biomarkers in the interstitial fluid, biological information about cells and tissues can be obtained. It is a safe, painless, minimally invasive method, and it is convenient and easy to use. At the same time, the nanozyme colorimetric method is combined to construct a uric acid detection system. The DNA / metal organic framework composite nanozyme combines DNA enzymes with metal organic frameworks, has advantages in sequence variability, information, structural designability, and functional controllability, and also has excellent peroxidase-like activity. The colorimetric method based on nanozymes has received widespread attention in the field of uric acid detection. It is convenient, fast, simple and intuitive, and is conducive to the clinical diagnosis of related diseases. Summary of the invention

[0003] In response to the above defects or improvement needs of the prior art, the present invention provides a DNA / metal organic framework composite nanozyme, and provides a method for colorimetric detection of uric acid content using the composite nanozyme. The method extracts interstitial fluid from human skin through a hydrogel microneedle patch, and detects the biomarker uric acid in the interstitial fluid by composite nanozyme colorimetry. The composite nanozyme has peroxidase activity and catalyzes the color change of the substrate under the action of H2O2. The present invention solves the technical problems of high cost and instability of natural enzymes, low compliance of patients in blood testing, and susceptibility to infection.

[0004] A method for preparing a DNA / metal organic framework composite nanozyme, wherein the composite nanozyme is obtained by co-incubating a metal organic framework modified with a metal oxide with heme / G quadruplex DNA.

[0005] In the above technical scheme, the heme / G quadruplex DNA solution is used as the dispersion medium, the metal oxide-modified metal organic framework and the heme / G quadruplex DNA solution are ultrasonicated for 5 to 30 minutes, and the temperature is 0 to 40°C and then incubated for 5 to 300 minutes to obtain a DNA / metal organic framework composite nanozyme solution with a mass concentration of 0.1 to 10 mg / mL, wherein:

[0006] The heme / G quadruplex DNA solution is obtained by mixing a 0.4 μM heme solution and a 0.8 μM G quadruplex DNA solution in a volume ratio of 1:9 to 1:1.

[0007] In the above technical solution, the metal oxide modified metal organic framework is prepared by the following method:

[0008] The metal oxide and the metal organic framework are dispersed in deionized water in a mass ratio of 1:1-10, mixed, ultrasonicated for 5-60 minutes, centrifuged at 3000 rpm for 5-30 minutes, washed, centrifuged, and dried at 40-80° C. to obtain a metal oxide modified metal organic framework.

[0009] Among them, the metal organic framework is a cerium metal organic framework, an iron metal organic framework, a zirconium metal organic framework, and a cobalt metal organic framework; the metal oxide is cupric oxide, cuprous oxide, ferrosoferric oxide, cerium dioxide, and ruthenium oxide.

[0010] In the above technical solution, the ratio of the metal oxide and metal organic framework to deionized water is 1 mg: 1 to 10 mL.

[0011] Furthermore, the metal organic framework is prepared by the following method: dissolving metal salt and terephthalic acid in N,N'-dimethylformamide at a mass ratio of 1:1 to 10 to obtain a mixed solution, placing the mixed solution in a reactor for hydrothermal reaction at a reaction temperature of 120°C and a reaction time of 6 to 48 hours.

[0012] The metal salt is zirconium chloride, ferric chloride, cerium nitrate, and cobalt nitrate; the ratio of the metal salt to N,N'-dimethylformamide is 1 mg:0.1-1 mL.

[0013] In the above technical scheme, the heme / G quadruplex DNA solution is prepared by the following method: the oligonucleotide sequence dry powder is centrifuged at 4000rpm for 5min, deionized water is added to prepare a 100μM mother solution, the mother solution is diluted to 0.8μM with 10mM Tris-HCl buffer (pH7.0), and incubated at room temperature for 3h to obtain a G quadruplex DNA solution, 0.4μM heme solution is added, the heme solution and the G quadruplex DNA solution are mixed in a volume ratio of 1:9 to 1:1, and the mixture is allowed to stand for 3h to obtain a heme / G quadruplex DNA solution, which is stored at 4°C.

[0014] In the above technical solution, the oligonucleotide sequence is 5'-TTGGGTGGGTGGGTGGGTC-3', which can be purchased commercially or prepared using the method disclosed in the prior art.

[0015] Preferably, the heme solution and the G quadruplex DNA solution are mixed at a volume ratio of 3:7.

[0016] Furthermore, the G quadruplex is a parallel quadruplex or an antiparallel quadruplex.

[0017] Another object of the present invention is to provide a DNA / metal organic framework composite nanozyme prepared by the above method.

[0018] Furthermore, the composite nanozyme has peroxidase activity.

[0019] The DNA / metal organic framework composite nanozyme of the present invention has peroxidase-like activity and can catalyze the chromogenic substrate TMB under the action of H2O2 to cause the solution to change color.

[0020] Another object of the present invention is to provide the use of the above-mentioned DNA / metal organic framework composite nanozyme in the quantitative or qualitative detection of uric acid.

[0021] Another object of the present invention is to provide a microneedle detection system based on the composite nanozyme.

[0022] A microneedle detection system based on the composite nanozyme, the detection system comprising the composite nanozyme and a hydrogel microneedle for extracting skin interstitial fluid.

[0023] In the above technical solution, the hydrogel microneedle patch can extract skin interstitial fluid, and the hydrogel microneedle patch can be prepared according to the method disclosed in the prior art, such as physical cross-linking method or chemical cross-linking method.

[0024] Furthermore, the physical cross-linking method is a freeze-thaw cycle method, and the chemical cross-linking method can use an aldehyde cross-linking agent such as glutaraldehyde.

[0025] Furthermore, the hydrogel microneedle patch can be prepared by the following method: 0.4g of polyvinyl alcohol is added to deionized water to prepare a 10wt% solution; 0.02g of sodium polyacrylate is added to deionized water to prepare a 0.5wt% solution, stirred evenly, 20μL of cross-linking agent glutaraldehyde is added, and stirred evenly to obtain a matrix solution; the matrix solution is injected into the PDMS mold, centrifuged, and dried to obtain a microneedle patch.

[0026] Furthermore, the matrix material includes polyvinyl alcohol, polyvinyl pyrrolidone, sodium polyacrylate, chitosan, sodium alginate, and hyaluronic acid.

[0027] Furthermore, the needle tip is pyramidal or conical, the needle tip length is 100-1000 μm, and the distance between two adjacent needle tips is 100-1500 μm.

[0028] A uric acid detection method based on the microneedle detection system of the composite nanozyme comprises the following steps: transferring the microneedle to a centrifuge tube containing 1 mL of PBS solution, and placing the microneedle in a water bath at 30 to 80° C. for 5 to 30 minutes or centrifuging the tube at a speed of 1000 to 3000 rpm for 5 to 30 minutes; detecting and analyzing the recovered uric acid using a DNA / metal organic framework composite nanozyme colorimetric solution, wherein the volume ratio of the recovered liquid to the colorimetric solution is 1:1 to 10, and reacting the solution at room temperature for 5 to 30 minutes before testing.

[0029] In the above technical scheme, the DNA / metal organic framework composite nanozyme provided by the present invention has peroxidase-like activity, and under the action of H2O2, it can change the color of the substrate to obtain a stable color-developing solution.

[0030] The color developing solution is composed of the following components: 75 μL of 1 mg / mL DNA / metal organic framework composite nanozyme solution, 25 μL of 10 mM TMB solution, 125 μL of 10 mM H2O2 solution, and 50 μL of pH 5.5 sodium acetate buffer solution.

[0031] The present invention also provides applications of the composite nanozyme combined with microneedle detection system in the field of disease detection, food detection or environmental monitoring.

[0032] The beneficial effects of the present invention are as follows: the DNA / metal organic framework composite nanozyme provided by the present invention has peroxidase activity, catalyzes the substrate to produce color changes under the action of H2O2, and can be used for the detection of uric acid. The present invention further provides a composite nanozyme combined with a microneedle detection system, which can be used for the visual detection of uric acid in interstitial fluid. The method extracts interstitial fluid from human skin through a hydrogel microneedle patch, and detects the biomarker uric acid in the interstitial fluid by means of a composite nanozyme colorimetric method. Compared with the method of detecting uric acid in blood, this method of detecting uric acid is minimally invasive and painless, simple and rapid, intuitive and accurate. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 It is a schematic diagram of the detection principle of the microneedle patch for colorimetric detection of uric acid concentration provided in Example 1 of the present invention; as shown in the figure, when the microneedle patch provided by the present invention is used for colorimetric detection of uric acid concentration, the microneedles extract the interstitial fluid in the skin, and the uric acid in the interstitial fluid is recovered; the DNA enzyme composite metal organic framework with peroxidase-like activity oxidizes the chromogenic substance under the action of H2O2 to produce a color change, and uric acid inhibits this process, thereby realizing the detection of uric acid in the interstitial fluid.

[0034] Figure 2 is a microscope image of the microneedle provided in Example 1 of the present invention;

[0035] Figure 3is a schematic diagram of the swelling performance of the microneedle patch provided in Example 1 of the present invention in agarose gel;

[0036] Figure 4 Schematic diagram of the mechanical strength of the microneedle patch provided in Example 1 of the present invention;

[0037] Figure 5 The enzyme activity of the composite nanozyme prepared in Example 1 of the present invention was investigated;

[0038] Figure 6 The composite nanozyme prepared in Example 1 of the present invention is used to detect uric acid.

[0039] Figure 7 The composite nanozyme and uric acid meter prepared in Example 1 of the present invention are used to perform in vivo detection of uric acid. DETAILED DESCRIPTION

[0040] The following non-limiting embodiments may enable a person skilled in the art to more fully understand the present invention, but are not intended to limit the present invention in any way.

[0041] The test methods described in the following examples are conventional methods unless otherwise specified; the reagents and materials described are commercially available unless otherwise specified.

[0042] Example 1

[0043] 1. Preparation of hydrogel microneedle patch

[0044] A method for preparing a hydrogel microneedle patch for colorimetric detection of uric acid concentration, the method comprising the following steps:

[0045] 1. Add 0.4 g of polyvinyl alcohol to deionized water to prepare a 10 wt% solution; add 0.02 g of sodium polyacrylate to deionized water to prepare a 0.5 wt% solution, stir evenly, add 20 μL of cross-linking agent glutaraldehyde, stir evenly to obtain a matrix solution.

[0046] 2. Pour the matrix solution evenly into the PDMS microneedle mold, centrifuge to fill the microneedle mold with the matrix solution, and then demould it after drying to obtain a microneedle patch. The size of the microneedle patch is 12.4*12.4mm, the needle length is 800μm, and the array is 11*11.

[0047] The obtained microneedle patch was observed under a microscope. Figure 2 It can be seen that the microneedle patch prepared in this embodiment is pyramid-shaped and the microneedle tips are complete.

[0048] The microneedle patch prepared by the present invention was inserted into agarose gel (1.4 wt%) after being pierced with a sealing film to test its swelling performance. The results are as follows: Figure 3As shown, the microneedle patch reached swelling equilibrium in 15 min and had a good ability to extract interstitial fluid.

[0049] The mechanical strength of the microneedle patch prepared by the present invention was investigated, and the results are as follows Figure 4 As shown, the microneedle patch has good mechanical strength.

[0050] 2. Preparation of DNA / metal-organic framework composite nanozymes

[0051] A method for preparing a composite nanozyme for colorimetric detection of uric acid concentration, the method comprising the following steps:

[0052] 0.13g of copper chloride and 3.0g of polyvinyl pyrrolidone were added to 100mL of deionized water and placed in a water bath at 25°C until fully dissolved. After dissolution, 10mL of sodium hydroxide (concentration of 2M) was added to form a turbid blue solution, and stirring was continued for 30min. 10mL of ascorbic acid was added, and the mixture was stirred at 60°C for 3h, centrifuged, washed, and dried to obtain cuprous oxide.

[0053] Dissolve 0.14g zirconium chloride and 0.10g terephthalic acid in 25mL N,N'-dimethylformamide, place the reactor at 120℃ for 24h, centrifuge, wash and dry to obtain a zirconium metal organic framework. Disperse 20mg cuprous oxide and 20mg zirconium metal organic framework in 40mL deionized water, ultrasonicate for 40min, centrifuge at 3000rpm for 15min, wash and dry to obtain a modified metal organic framework. Disperse 1mg of the modified metal organic framework in 1mL of heme / G quadruplex DNA solution (mix 0.8μM G quadruplex DNA solution and 0.4μM heme solution in a volume ratio of 7:3), ultrasonicate for 20min at room temperature, and continue to incubate at 4℃ for 30min to obtain a DNA / metal organic framework composite nanozyme solution.

[0054] The enzyme activity of the obtained DNA / metal organic framework composite nanozyme was compared with that of a single nanozyme. 1 mg of modified metal organic framework, 1 mg of metal oxide, and 1 mg of metal organic framework were dispersed in 1 mL of deionized water to obtain a single nanozyme solution.

[0055] 75 μL of 1 mg / mL DNA / metal organic framework composite nanozyme solution, 25 μL of 10 mM TMB solution, 125 μL of 10 mM H2O2 solution, and 50 μL of pH 5.5 sodium acetate buffer solution were reacted at room temperature for 30 min to obtain solution 1.

[0056] 75 μL of 1 mg / mL modified metal organic framework solution, 25 μL of 10 mM TMB solution, 125 μL of 10 mM H2O2 solution, and 50 μL of pH 5.5 sodium acetate buffer solution were reacted at room temperature for 30 min to obtain solution 2.

[0057] 75 μL of 1 mg / mL metal oxide solution, 25 μL of 10 mM TMB solution, 125 μL of 10 mM H2O2 solution, and 50 μL of pH 5.5 sodium acetate buffer solution were reacted at room temperature for 30 min to obtain solution 3.

[0058] 75 μL of 1 mg / mL metal organic framework solution, 25 μL of 10 mM TMB solution, 125 μL of 10 mM H2O2 solution, and 50 μL of pH 5.5 sodium acetate buffer solution were reacted at room temperature for 30 min to obtain solution 4.

[0059] With the aid of an ELISA reader, the spectrum was scanned at 500-800 nm. Figure 5 As shown, the DNA / metal organic framework composite nanozyme has higher enzyme activity.

[0060] 3. Uric acid detection method

[0061] The DNA / metal organic framework composite nanozyme solution prepared by the present invention is used to detect uric acid and establish a standard curve , the method comprises the following steps:

[0062] 75 μL of 1 mg / mL DNA / metal organic framework composite nanozyme solution, 25 μL of 10 mM TMB solution, 125 μL of 10 mM H2O2 solution, and 50 μL of pH 5.5 sodium acetate buffer solution were reacted at room temperature for 30 min to obtain a color development solution. 100 μL of the reaction solution was added to a 96-well plate and the absorbance was measured at 652 nm. The absorbance was A 空 Prepare 10, 25, 100, 200, 500 μM uric acid solutions, add 50 μL of uric acid solution and 100 μL of colorimetric solution into a centrifuge tube, vortex mix, react at room temperature for 20 min, take 100 μL of the reaction solution and add it to a 96-well plate, measure the absorbance at 652 nm, and obtain A. 测 A standard curve was established with the concentration C of uric acid solution as the horizontal axis and the absorbance difference ΔA (ΔA = A 空 -A 测 ) is the vertical axis, and the result is Figure 6 As shown, the standard curve y = 0.0012x + 0.0108 (R 2 =0.9997).

[0063] The DNA / metal organic framework composite nanozyme solution prepared by the present invention is used to detect uric acid in vitro, and the method comprises the following steps:

[0064] Using pig skin as an in vitro model, the pig skin was thawed with physiological saline and soaked in different concentrations of uric acid solution for 30 minutes (0.1, 0.5, 1, 3, 5mM). The pig skin was taken out and dried with filter paper. After the microneedle pressed the pig skin for 10 minutes, the microneedle was transferred to a centrifuge tube, 1mL of PBS solution was added, and it was placed in a 40℃ water bath for 10 minutes to recover the uric acid extracted by the microneedle. The recovered liquid was transferred to a new centrifuge tube, and the recovered uric acid was detected with the help of the composite nanozyme. 75μL of 1mg / mL DNA / metal organic framework composite nanozyme solution, 25μL of 10mMTMB, 125μL of 10mMH2O2, and 50μL of pH5.5 sodium acetate buffer solution were reacted at room temperature for 30 minutes to obtain a color solution (blue). 50μL of the recovered liquid and 100μL of the color solution were added to the centrifuge tube, vortexed and mixed, and reacted at room temperature for 20 minutes. As the uric acid concentration in the recovered solution increased, the color solution faded.

[0065] The DNA / metal organic framework composite nanozyme solution prepared by the present invention is used to detect uric acid in vivo, and the method comprises the following steps:

[0066] Using SD rats as a model, the SD rats were divided into three groups. The first group was injected with 250 mg / kg uric acid and 300 mg / kg potassium oxonate (UA+Potassiumoxonate); the second group was injected with 250 mg / kg uric acid (UA); and the third group was injected with normal saline (Saline).

[0067] After pressing the hydrogel microneedle on the rat's back skin for 10 minutes, the microneedle was transferred to a centrifuge tube, 1 mL of PBS solution was added, and it was placed in a 40°C water bath for 10 minutes to recover the uric acid extracted by the microneedle. The recovered liquid was transferred to a new centrifuge tube, and the recovered uric acid was detected with the help of the composite nanozyme. 75 μL of 1 mg / mL DNA / metal organic framework composite nanozyme solution, 25 μL of 10 mM TMB solution, 125 μL of 10 mM H2O2 solution, and 50 μL of pH 5.5 sodium acetate buffer solution were reacted at room temperature for 30 minutes to obtain a colorimetric solution. 50 μL of the recovered liquid and 100 μL of the colorimetric solution were added to the centrifuge tube, vortexed to mix, and reacted at room temperature for 20 minutes. 100 μL of the reaction solution was added to a 96-well plate, the absorbance was measured at 652 nm, and the in vivo concentration was calculated by substituting it into the standard curve. The results were compared with the uric acid meter, as shown in Figure 7 As shown, the calculated in vivo results of the first group (266 μM) were basically consistent with the uric acid meter (273 μM). The uric acid meter showed that L0 represented a uric acid value lower than 180 μM. The second group (188 μM) and the third group (125 μM) also confirmed this result through calculation.

Claims

1. A method for preparing a DNA / metal organic framework composite nanozyme, Features: The composite nanozyme is obtained by incubating a metal oxide-modified metal organic framework with heme / G quadruplex DNA.

2. The method according to claim 1, Features: The heme / G quadruplex DNA solution is used as a dispersion medium, the metal oxide-modified metal organic framework and the heme / G quadruplex DNA solution are ultrasonically treated for 5 to 30 minutes, and the temperature is 0 to 40° C. and then incubated for 5 to 300 minutes to obtain a DNA / metal organic framework composite nanozyme solution with a mass concentration of 0.1 to 10 mg / mL, wherein: The heme / G quadruplex DNA solution is obtained by mixing a 0.4 μM heme solution and a 0.8 μM G quadruplex DNA solution in a volume ratio of 1:9 to 1:

1.

3. The method according to claim 2, Features: The heme / G quadruplex DNA solution was prepared by the following method: the oligonucleotide sequence dry powder was centrifuged at 4000 rpm for 5 min, deionized water was added to prepare a 100 μM mother solution, the mother solution was diluted to 0.8 μM with 10 mM Tris-HCl buffer (pH 7.0), and the mixture was incubated at room temperature for 3 h to obtain a G quadruplex DNA solution, 0.4 μM heme solution was added, the heme solution and the G quadruplex DNA solution were mixed at a volume ratio of 1:9 to 1:1, and the mixture was incubated for 3 h to obtain a heme / G quadruplex DNA solution, which was stored at 4°C.

4. The method according to claim 1, Features: The metal oxide modified metal organic framework is prepared by the following method: The metal oxide and the metal organic framework are dispersed in deionized water and mixed in a mass ratio of 1:1 to 10, ultrasonicated for 5 to 60 minutes, centrifuged at 3000 rpm for 5 to 30 minutes, washed, centrifuged, and dried at 40 to 80°C. The metal organic framework is a cerium metal organic framework, an iron metal organic framework, a zirconium metal organic framework, or a cobalt metal organic framework; the metal oxide is cupric oxide, cuprous oxide, ferrosoferric oxide, cerium dioxide, or ruthenium oxide.

5. The method according to claim 3, Features: The oligonucleotide sequence is 5'-TTGGGTGGGTGGGTGGGTC-3'.

6. The DNA / metal organic framework composite nanozyme prepared by the method of claims 1 to 5, Features: The composite nanozyme has peroxidase activity and can 2 O 2 ) can catalyze the chromogenic substrate 3,3',5,5'-tetramethylbenzidine (TMB) to cause the solution to change color.

7. Use of the composite nanozyme according to claim 6 in the quantitative or qualitative detection of uric acid.

8. A microneedle detection system based on the composite nanozyme according to claim 1, the detection system comprising the composite nanozyme according to claim 7 and a hydrogel microneedle for extracting skin interstitial fluid.

9. A method for detecting uric acid based on the microneedle detection system of the composite nanozyme according to claim 8, Features: The method is a colorimetric method, specifically: The microneedle was transferred to a centrifuge tube containing 1 mL of PBS solution, and then placed in a water bath at 30-80°C for 5-30 min or centrifuged at 1000-3000 rpm for 5-30 min. The recovered uric acid was detected and analyzed using a DNA / metal organic framework composite nanozyme colorimetric solution, with the volume ratio of the recovered liquid to the colorimetric solution being 1:1-10. The reaction was carried out at room temperature for 5-30 min and the sample was tested. The color development solution consists of 75 μL of 1 mg / mL DNA / metal organic framework composite nanozyme solution, 25 μL of 10 mM TMB solution, and 10 mM H 2 O 2 The solution was 125 μL and the pH 5.5 sodium acetate buffer solution was 50 μL, and the mixture was reacted at room temperature for 30 min.

Citation Information

Patent Citations

  • DNA (deoxyribonucleic acid) functionalized MOF (metal organic framework) as well as preparation method and application thereof

    CN117720739A

  • PBS(Peripheral Blood Smear) automatic description system according to automatic hematology analyzer's results

    KR1020240116094A

Cited By

  • Metal organic framework nano-enzyme aerogel / DNA (deoxyribonucleic acid) detection liquid as well as preparation method and application thereof

    CN121016850A